Microbiome Liquid Biopsy May Refine High-Dose Chemotherapy Decisions in Relapsed Germ Cell TumorsBy adminFebruary 20, 20260 Credit: jxfzsy/Getty Images When standard chemotherapy fails in young men with germ cell tumors, options become limited and often grueling.…
Probiotics What stakeholders can learn from NAD’s national 2025 dietary supplement case decisionsBy adminNovember 26, 20250 In a market where consumers increasingly expect supplements to deliver measurable benefits, transparent and responsible marketing is essential. At their…
DNA & Genetics Accelerating Clinical Decisions Through Faster Access to Imaging DataBy adminNovember 16, 20250 Clinical trials generate a wealth of imaging data, but trial sponsors, site investigators, drug developers, and other stakeholders often can’t…